Skip to main content

Table 2 Outcomes of infectious disease or hematological disease patients in with or without hypofibrinogenemia

From: Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa

 

Infectious diseases

Hematological diseases

Fibrinogen, g/L

≥1.5

< 1.5

p-value

≥1.5

< 1.5

p-value

28-day survival

1846

1321 (71.6)

212

106 (50.0)

< 0.0001

807

587 (72.7)

312

220 (70.5)

0.4566

JMHW DIC resolution

683

427 (62.5)

98

47 (48.0)

0.0058

476

275 (57.8)

231

113 (48.9)

0.0265

ISTH DIC resolution

651

449 (69.0)

119

57 (47.9)

< 0.0001

385

240 (62.3)

202

116 (57.4)

0.2472

JAAM DIC resolution

1266

513 (40.5)

156

30 (19.2)

< 0.000

 

Clinical course of bleeding symptoms

        

Disappeared+Improved

216

99 (45.8)

48

24 (50.0)

0.6007

217

110 (50.7)

142

86 (60.6)

0.0662

Unchanged+Exacerbated

216

117 (54.2)

48

24 (50.0)

 

217

107 (49.3)

142

56 (39.4)

 
  1. Data are given as n (%)
  2. DIC, disseminated intravascular coagulation; JMHW, Japanese Ministry of Health and Welfare; ISTH, International Society of Thrombosis Haemostasis;
  3. JAAM, Japanese Association for Acute Medicine